ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,765.04
-0.47%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.675
0.00%
Brent Oil
83.76
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. SELLAS Life Sciences Group Inc (SLS)

  7. SELLAS Life Sciences Group Inc (SLS) ニュース

SLS

SELLAS Life Sciences (SLS)

SELLAS Life Sciences Group Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:SLS
日付受信時刻ニュースソース見出しコード企業名
2024/05/1505 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLSSELLAS Life Sciences Group Inc
2024/05/1505 : 01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SLSSELLAS Life Sciences Group Inc
2024/03/1205 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLSSELLAS Life Sciences Group Inc
2024/03/0906 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLSSELLAS Life Sciences Group Inc
2024/03/0606 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLSSELLAS Life Sciences Group Inc
2024/02/1706 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLSSELLAS Life Sciences Group Inc
2024/01/2520 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLSSELLAS Life Sciences Group Inc
2024/01/2520 : 03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLSSELLAS Life Sciences Group Inc
2024/01/2520 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLSSELLAS Life Sciences Group Inc
2024/01/2520 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLSSELLAS Life Sciences Group Inc
2024/01/2520 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLSSELLAS Life Sciences Group Inc
2024/01/2006 : 11Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SLSSELLAS Life Sciences Group Inc
2024/01/0907 : 07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLSSELLAS Life Sciences Group Inc
2024/01/0606 : 27Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SLSSELLAS Life Sciences Group Inc
2024/01/0407 : 25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLSSELLAS Life Sciences Group Inc
2023/12/2223 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLSSELLAS Life Sciences Group Inc
2023/12/1406 : 21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLSSELLAS Life Sciences Group Inc
2023/12/0906 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLSSELLAS Life Sciences Group Inc
2023/12/0906 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLSSELLAS Life Sciences Group Inc
2023/12/0906 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLSSELLAS Life Sciences Group Inc
2023/12/0906 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLSSELLAS Life Sciences Group Inc
2023/11/1006 : 07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLSSELLAS Life Sciences Group Inc
2023/11/1006 : 01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SLSSELLAS Life Sciences Group Inc
2023/11/0205 : 05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SLSSELLAS Life Sciences Group Inc
2023/10/3121 : 11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLSSELLAS Life Sciences Group Inc
2023/10/1621 : 51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLSSELLAS Life Sciences Group Inc
2023/10/1321 : 29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLSSELLAS Life Sciences Group Inc
2023/08/1105 : 12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLSSELLAS Life Sciences Group Inc
2023/08/1105 : 02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SLSSELLAS Life Sciences Group Inc
2023/06/2119 : 04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SLSSELLAS Life Sciences Group Inc
 Showing the most relevant articles for your search:NASDAQ:SLS

最近閲覧した銘柄

LSE
0A16
Vanguard S&p Small-cap 6...
EU
ALMCE
Mon Courtier Energie Gro...
AMEX
IGLD
FT Vest Gold Strategy Ta...
USOTC
NBBTF
Natural Beauty Bio Techn... (PK)
TSXV
RCZ
NASDAQ
SPRNX
Sprucegrove Internationa...
BIT
UC3REN
Unicredit Bank
TSX
TPRF
TD Active Preferred Shar...
DGFX
XRDUSDT
E-RADIX
BIT
UC8FRZ
Unicredit Bank
OKEX
IDUSDT
Space ID
LSE
13LJ
Anglo Am. 22
ASX
DRIV
BetaShares
BOV
CPLE3R
COPEL ON
BIT
UC8YK9
Unicredit Bank
BIT
UC1C4X
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有